buprenorphine + codeine + tramadol

This is a combination of three opioid analgesics—buprenorphine, codeine, and tramadol. Each component acts on the central nervous system to relieve pain but through slightly different mechanisms: - Buprenorphine is a partial agonist at the mu-opioid receptor with high affinity but limited intrinsic activity, providing analgesia with a ceiling effect for respiratory depression. It also acts as an antagonist at kappa-opioid receptors. - Codeine is a prodrug that requires metabolic activation (primarily via CYP2D6) to morphine, which then acts as an agonist at mu-opioid receptors to provide analgesia. - Tramadol is both a weak mu-opioid receptor agonist and an inhibitor of serotonin and norepinephrine reuptake (SNRI), contributing to its multimodal pain-relieving effects. The combination would theoretically provide additive or synergistic analgesic effects due to their complementary mechanisms. However, combining multiple opioids increases the risk of adverse effects such as respiratory depression, sedation, serotonin syndrome (especially due’s SNRI activity), dependence, abuse potential, and overdose. There are no known approved pharmaceutical products containing all three agents together; such combinations are generally not recommended in clinical practice due to safety concerns[1][3][4][5].

Other names

buprenorphine and codeine and tramadolbuprenorphine/codeine/tramadol